YING-CHIA CHENG: Open Payments
NPI 1811257058 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 29 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $103 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $367 |
| Alkermes, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: VRAYLAR, LYBALVI, COBENFY, ABILIFY MAINTENA, INGREZZA, Dyanavel XR, SPRAVATO.
Industry payments across NV — which companies pay providers there.
